Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Pathologie-Biologie|April 7, 2007
[Circadian behaviour of host versus tumour outcome. A review]C Focan, F Lévi, P InnominatoCold Spring Harbor Symposia on Quantitative Biology|April 19, 2008
Cross-talks between circadian timing system and cell division cycle determine cancer biology and therapeuticsF Lévi, E Filipski, I Iurisci, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 2, 2010
Treatment with rituximab, dexamethasone, high-dose cytarabine, and oxaliplatin (R-DHAOx) produces a strong long-term antitumor effect in previously treated patients with follicular non-Hodgkin's lymphomaD Machover, B Delmas-Marsalet, S C Misra, et al.Medical Oncology (Northwood, London, England)|November 6, 2010
Feasibility of cetuximab given with a simplified schedule every 2 weeks in advanced colorectal cancer: a multicenter, retrospective analysisM Bouchahda, T Macarulla, G Liedo, et al.Targeted Oncology|November 26, 2014
Colorectal liver metastases are more often super wild type. Toward treatment based on metastatic site genotyping?M A Allard, R Saffroy, P Bouvet de la Maisonneuve, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2015
Conversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIVF A Lévi, V Boige, M Hebbar, et al.Pageof 1